KRAS and neoplasm: RMC-9805 reacts covalently with Asp12, thereby attenuating KRAS G12D downstream signaling specifically over KRAS WT and other KRAS mutants, and it restricts tumor growth in xenograft PDAC and CRC mouse models (33).